Sanofi Loses Suit Against FDA Over Generic Eloxatin
A federal judge on Monday threw out a lawsuit brought by Sanofi-Aventis U.S. LLC and Debiopharm SA that sought to force the U.S. Food and Drug Administration to rescind its approvals...To view the full article, register now.
Already a subscriber? Click here to view full article